A comparative study of PSPVP and PSIBG in the treatment of stage II–III Kummell’s disease
Bio-Medical Materials and Engineering2022Vol. 34(3), pp. 261–276
Citations Over Time
Abstract
Both PSPVP and PSIBG can achieve good early clinical efficacy in the treatment of stage II-III Kummell's disease, with PSPVP being relatively less invasive while producing a poorer orthopedic effect and more complications than PSIBG.
Related Papers
- → Incidence and Risk Factors for Proximal and Distal Junctional Kyphosis Following Surgical Treatment for Scheuermann Kyphosis(2009)207 cited
- → Preventive Vertebroplasty for Adjacent Vertebral Bodies: A Good Solution to Reduce Adjacent Vertebral Fracture after Percutaneous Vertebroplasty(2012)33 cited
- → Predicting post-laminoplasty kyphosis in cervical spondylotic myelopathy patients without preoperative kyphosis: a retrospective study(2023)7 cited
- The Application of Rotate 3D-DA in the Percutaneous Vertebroplasty(2007)
- Выбор оптимального уровня дистальной фиксации для коррекции гиперкифоза при болезни шейерманна(2012)